Document Detail


Extraglycemic effects of glp-1-based therapeutics: Addressing metabolic and cardiovascular risks associated with type 2 diabetes.
MedLine Citation:
PMID:  23332049     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
CONTEXT: To examine whether widespread tissue expression of the glucagon-like peptide (GLP)-1 receptor supports the possibility of differential effects of GLP-1-based therapeutics on cardiac function, blood pressure, food intake, gastric emptying, and other regulatory activities. GLP-1 receptor agonists (RAs) have demonstrated pleiotropic effects on overweight/obesity, hypertension, dyslipidemia, and cardiovascular (CV) disease. Food-regulatory effects have been demonstrated in preclinical and clinical trials, including reduced gastric motility and food intake leading to body weight reductions. Native GLP-1 and GLP-1 RAs have demonstrated cardioprotective effects in preclinical models. EVIDENCE ACQUISITION: Using PubMed, we performed a search of the recent literature on GLP-1 and GLP-1 RAs. EVIDENCE SYNTHESIS: Preliminary clinical data indicate native GLP-1 has beneficial effects on endothelial cell function and vascular inflammation. Native GLP-1 and GLP-1 RAs have demonstrated renoprotective and antihypertensive effects, and reductions in lipid parameters. The GLP-1 RA liraglutide has also demonstrated positive effects on such markers of endothelial dysfunction as tumor necrosis factor-α and plasminogen activator inhibitor-1. CONCLUSION: Preliminary data suggest GLP-1 RAs could benefit type 2 diabetes patients at risk for CV comorbidities. Additional studies are needed to confirm the extraglycemic and extrapancreatic effects and determine whether outcomes will translate into beneficial effects for patient care.
Authors:
Susan Herzlinger; Edward S Horton
Related Documents :
19341779 - Safety assessment of cry1ab/ac fusion protein.
15144469 - Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin...
2150429 - Allergic manifestations due to castor beans: an undue risk for the dock workers handlin...
20480889 - Validation procedures for quantitative food allergen elisa methods: community guidance ...
9554579 - Hematoxylin procedure for staining mature pollen grains in maize with dimethylsulfoxide...
9756209 - Food allergy with monovalent sensitivity to poultry meat.
24160249 - Processed foods available in the pacific islands.
19341779 - Safety assessment of cry1ab/ac fusion protein.
17256489 - Evolution of the snow area index of the subarctic snowpack in central alaska over a who...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-14
Journal Detail:
Title:  Diabetes research and clinical practice     Volume:  -     ISSN:  1872-8227     ISO Abbreviation:  Diabetes Res. Clin. Pract.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8508335     Medline TA:  Diabetes Res Clin Pract     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Joslin Diabetes Center, Harvard Medical School, Boston, MA, United States.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Apelin-13 regulates proliferation, migration and survival of retinal Müller cells under hypoxia.
Next Document:  Impact of gestational diabetes mellitus screening strategies on perinatal outcomes: A simulation stu...